1kwr › Citations

Successful virtual screening for novel inhibitors of human carbonic anhydrase: strategy and experimental confirmation.

Grüneberg S, Stubbs MT, Klebe G
J Med Chem 45 3588-602 (2002)
Cited: 60 times
EuropePMC logo PMID: 12166932

Abstract

Virtual screening of compound libraries is an alternative and complementary approach to high-throughput screening in the lead discovery process. A new strategy is described to search for possible leads of human carbonic anhydrase II, applying a protocol of several consecutive hierarchical filters involving a preselection based on functional group requirements and fast pharmacophore matching. A suitable pharmacophore is derived by a sophisticated "hot spot" analysis of the binding site to detect regions favorable for protein-ligand interactions. In subsequent steps, molecular similarity with known reference ligands is used to rerank the hits from the pharmacophore matching. Finally the best scored candidates are docked flexibly into the protein binding pocket. After examination of the affinity predictions, 13 compounds were selected for experimental testing. Of these 13, three could be shown to be subnanomolar, one is nanomolar, while a further seven are micromolar inhibitors. The binding mode of two hits could be confirmed by crystal structure analysis. The novelty of the discovered leads is best supported by the fact that a search in the patent literature showed the newly discovered subnanomolar compounds to comprise scaffolds not yet covered by existing patents.

Reviews - 1kwr mentioned but not cited (1)

  1. Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding. Krishnamurthy VM, Kaufman GK, Urbach AR, Gitlin I, Gudiksen KL, Weibel DB, Whitesides GM. Chem Rev 108 946-1051 (2008)


Reviews citing this publication (11)

  1. Virtual screening of chemical libraries. Shoichet BK. Nature 432 862-865 (2004)
  2. Integration of virtual and high-throughput screening. Bajorath J. Nat Rev Drug Discov 1 882-894 (2002)
  3. Virtual ligand screening: strategies, perspectives and limitations. Klebe G. Drug Discov Today 11 580-594 (2006)
  4. Integrating virtual screening in lead discovery. Oprea TI, Matter H. Curr Opin Chem Biol 8 349-358 (2004)
  5. C-H...O and other weak hydrogen bonds. From crystal engineering to virtual screening. Desiraju GR. Chem Commun (Camb) 2995-3001 (2005)
  6. Recent advances in computer-aided drug design. Song CM, Lim SJ, Tong JC. Brief Bioinform 10 579-591 (2009)
  7. Docking screens: right for the right reasons? Kolb P, Irwin JJ. Curr Top Med Chem 9 755-770 (2009)
  8. Target-biased scoring approaches and expert systems in structure-based virtual screening. Jansen JM, Martin EJ. Curr Opin Chem Biol 8 359-364 (2004)
  9. Charting a Path to Success in Virtual Screening. Forli S. Molecules 20 18732-18758 (2015)
  10. Thermodynamic, kinetic, and structural parameterization of human carbonic anhydrase interactions toward enhanced inhibitor design. Linkuvienė V, Zubrienė A, Manakova E, Petrauskas V, Baranauskienė L, Zakšauskas A, Smirnov A, Gražulis S, Ladbury JE, Matulis D. Q Rev Biophys 51 e10 (2018)
  11. Ligand discovery and virtual screening using the program LIDAEUS. Taylor P, Blackburn E, Sheng YG, Harding S, Hsin KY, Kan D, Shave S, Walkinshaw MD. Br J Pharmacol 153 Suppl 1 S55-67 (2008)

Articles citing this publication (48)

  1. Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. Mysinger MM, Carchia M, Irwin JJ, Shoichet BK. J Med Chem 55 6582-6594 (2012)
  2. Benchmarking sets for molecular docking. Huang N, Shoichet BK, Irwin JJ. J Med Chem 49 6789-6801 (2006)
  3. Evaluation of library ranking efficacy in virtual screening. Kontoyianni M, Sokol GS, McClellan LM. J Comput Chem 26 11-22 (2005)
  4. Comparison of structure- and ligand-based virtual screening protocols considering hit list complementarity and enrichment factors. Krüger DM, Evers A. ChemMedChem 5 148-158 (2010)
  5. Carbonic anhydrase inhibitors. Interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies. Güzel O, Temperini C, Innocenti A, Scozzafava A, Salman A, Supuran CT. Bioorg Med Chem Lett 18 152-158 (2008)
  6. A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site. Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R. Bioorg Med Chem 12 935-947 (2004)
  7. Carbonic anhydrase inhibitors: binding of an antiglaucoma glycosyl-sulfanilamide derivative to human isoform II and its consequences for the drug design of enzyme inhibitors incorporating sugar moieties. Di Fiore A, Scozzafava A, Winum JY, Montero JL, Pedone C, Supuran CT, De Simone G. Bioorg Med Chem Lett 17 1726-1731 (2007)
  8. Is it possible to increase hit rates in structure-based virtual screening by pharmacophore filtering? An investigation of the advantages and pitfalls of post-filtering. Muthas D, Sabnis YA, Lundborg M, Karlén A. J Mol Graph Model 26 1237-1251 (2008)
  9. Strategies to search and design stabilizers of protein-protein interactions: a feasibility study. Block P, Weskamp N, Wolf A, Klebe G. Proteins 68 170-186 (2007)
  10. Theoretical study of gas-phase acidity, pKa, lipophilicity, and solubility of some biologically active sulfonamides. Remko M, von der Lieth CW. Bioorg Med Chem 12 5395-5403 (2004)
  11. Comprehensive structural and functional characterization of the human kinome by protein structure modeling and ligand virtual screening. Brylinski M, Skolnick J. J Chem Inf Model 50 1839-1854 (2010)
  12. Carbonic anhydrase inhibitors: the X-ray crystal structure of ethoxzolamide complexed to human isoform II reveals the importance of thr200 and gln92 for obtaining tight-binding inhibitors. Di Fiore A, Pedone C, Antel J, Waldeck H, Witte A, Wurl M, Scozzafava A, Supuran CT, De Simone G. Bioorg Med Chem Lett 18 2669-2674 (2008)
  13. Structure-based discovery of potassium channel blockers from natural products: virtual screening and electrophysiological assay testing. Liu H, Li Y, Song M, Tan X, Cheng F, Zheng S, Shen J, Luo X, Ji R, Yue J, Hu G, Jiang H, Chen K. Chem Biol 10 1103-1113 (2003)
  14. Experimental validation of FINDSITE(comb) virtual ligand screening results for eight proteins yields novel nanomolar and micromolar binders. Srinivasan B, Zhou H, Kubanek J, Skolnick J. J Cheminform 6 16 (2014)
  15. Virtual screening for inhibitors of human aldose reductase. Kraemer O, Hazemann I, Podjarny AD, Klebe G. Proteins 55 814-823 (2004)
  16. Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of 5-amino-1,3,4-thiadiazole-2-sulfonamide and 5-(4-amino-3-chloro-5-fluorophenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide to human isoform II. Menchise V, De Simone G, Di Fiore A, Scozzafava A, Supuran CT. Bioorg Med Chem Lett 16 6204-6208 (2006)
  17. Identification of xenoestrogens in food additives by an integrated in silico and in vitro approach. Amadasi A, Mozzarelli A, Meda C, Maggi A, Cozzini P. Chem Res Toxicol 22 52-63 (2009)
  18. The effect of tightly bound water molecules on the structural interpretation of ligand-derived pharmacophore models. Lloyd DG, García-Sosa AT, Alberts IL, Todorov NP, Manceral RL. J Comput Aided Mol Des 18 89-100 (2004)
  19. Rational design of affinity peptide ligand by flexible docking simulation. Liu FF, Wang T, Dong XY, Sun Y. J Chromatogr A 1146 41-50 (2007)
  20. Scoring ligand similarity in structure-based virtual screening. Zavodszky MI, Rohatgi A, Van Voorst JR, Yan H, Kuhn LA. J Mol Recognit 22 280-292 (2009)
  21. Carbonic anhydrase inhibitors: synthesis and inhibition studies against mammalian isoforms I-XV with a series of 2-(hydrazinocarbonyl)-3-substituted-phenyl-1H-indole-5-sulfonamides. Güzel O, Innocenti A, Scozzafava A, Salman A, Parkkila S, Hilvo M, Supuran CT. Bioorg Med Chem 16 9113-9120 (2008)
  22. Crystallographic study of inhibitors of tRNA-guanine transglycosylase suggests a new structure-based pharmacophore for virtual screening. Brenk R, Meyer EA, Reuter K, Stubbs MT, Garcia GA, Diederich F, Klebe G. J Mol Biol 338 55-75 (2004)
  23. Carbonic anhydrase inhibitors: the X-ray crystal structure of the adduct of N-hydroxysulfamide with isozyme II explains why this new zinc binding function is effective in the design of potent inhibitors. Temperini C, Winum JY, Montero JL, Scozzafava A, Supuran CT. Bioorg Med Chem Lett 17 2795-2801 (2007)
  24. Carbonic anhydrase inhibitors. Interaction of 2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies. Temperini C, Cecchi A, Boyle NA, Scozzafava A, Cabeza JE, Wentworth P, Blackburn GM, Supuran CT. Bioorg Med Chem Lett 18 999-1005 (2008)
  25. Visualizing protein-ligand binding with chemical energy-wise decomposition (CHEWD): application to ligand binding in the kallikrein-8 S1 Site. Raza S, Ranaghan KE, van der Kamp MW, Woods CJ, Mulholland AJ, Azam SS. J Comput Aided Mol Des 33 461-475 (2019)
  26. Multiple-step virtual screening using VSM-G: overview and validation of fast geometrical matching enrichment. Beautrait A, Leroux V, Chavent M, Ghemtio L, Devignes MD, Smaïl-Tabbone M, Cai W, Shao X, Moreau G, Bladon P, Yao J, Maigret B. J Mol Model 14 135-148 (2008)
  27. Structure-based virtual screening and biological evaluation of potent and selective ADAM12 inhibitors. Oh M, Im I, Lee YJ, Kim YH, Yoon JH, Park HG, Higashiyama S, Kim YC, Park WJ. Bioorg Med Chem Lett 14 6071-6074 (2004)
  28. WinDock: structure-based drug discovery on Windows-based PCs. Hu Z, Southerland W. J Comput Chem 28 2347-2351 (2007)
  29. Spectroscopic and molecular modeling studies on binding of dorzolamide to bovine and human carbonic anhydrase II. Bijari N, Ghobadi S, Mahdiuni H, Khodarahmi R, Ghadami SA. Int J Biol Macromol 80 189-199 (2015)
  30. Carbonic anhydrase inhibitors. Interaction of the antitumor sulfamate EMD 486019 with twelve mammalian carbonic anhydrase isoforms: Kinetic and X-ray crystallographic studies. Temperini C, Innocenti A, Scozzafava A, Supuran CT. Bioorg Med Chem Lett 18 4282-4286 (2008)
  31. Integrated approach using protein and ligand information to analyze selectivity- and affinity-determining features of carbonic anhydrase isozymes. Hillebrecht A, Supuran CT, Klebe G. ChemMedChem 1 839-853 (2006)
  32. Prediction of activity and selectivity profiles of human Carbonic Anhydrase inhibitors using machine learning classification models. Tinivella A, Pinzi L, Rastelli G. J Cheminform 13 18 (2021)
  33. Virtual screening to enrich a compound collection with CDK2 inhibitors using docking, scoring, and composite scoring models. Cotesta S, Giordanetto F, Trosset JY, Crivori P, Kroemer RT, Stouten PF, Vulpetti A. Proteins 60 629-643 (2005)
  34. Carbonic anhydrase inhibitors: binding of indanesulfonamides to the human isoform II. D'Ambrosio K, Masereel B, Thiry A, Scozzafava A, Supuran CT, De Simone G. ChemMedChem 3 473-477 (2008)
  35. Scoring functions and enrichment: a case study on Hsp90. Konstantinou-Kirtay C, Mitchell JB, Lumley JA. BMC Bioinformatics 8 27 (2007)
  36. CFam: a chemical families database based on iterative selection of functional seeds and seed-directed compound clustering. Zhang C, Tao L, Qin C, Zhang P, Chen S, Zeng X, Xu F, Chen Z, Yang SY, Chen YZ. Nucleic Acids Res 43 D558-65 (2015)
  37. Combined enzyme and substrate design: grafting of a cooperative two-histidine catalytic motif into a protein targeted at the scissile bond in a designed ester substrate. Höst GE, Razkin J, Baltzer L, Jonsson BH. Chembiochem 8 1570-1576 (2007)
  38. 1α,25-Dihydroxyvitamin D3 inhibits the differentiation and bone resorption by osteoclasts generated from Wistar rat bone marrow-derived macrophages. Wang D, Gu JH, Chen Y, Zhao HY, Liu W, Song RL, Bian JC, Liu XZ, Yuan Y, Liu ZP. Exp Ther Med 10 1039-1044 (2015)
  39. Discriminating of HMG-CoA reductase inhibitors and decoys using self-organizing maps. Wang Z, Yan A. Mol Divers 15 655-663 (2011)
  40. Synthesis and evaluation of new carbonic anhydrase inhibitors. Xiao Z, Duan R, Cui W, Zhang Y, Zhang S, Chen F, Zhang Y, Liu J, Zhang D, Meng Y, Wang L, Wang H. Bioorg Med Chem 19 3221-3228 (2011)
  41. Collection and preparation of molecular databases for virtual screening. Saxena AK, Prathipati P. SAR QSAR Environ Res 17 371-392 (2006)
  42. Computational Prediction of the Binding Pose of Metal-Binding Pharmacophores. Karges J, Stokes RW, Cohen SM. ACS Med Chem Lett 13 428-435 (2022)
  43. Lead identification in post-genomics: computers as a complementary alternative. Klebe G. Drug Discov Today Technol 1 225-230 (2004)
  44. An Insight into the Structural Requirements and Pharmacophore Identification of Carbonic Anhydrase Inhibitors to Combat Oxidative Stress at High Altitudes: An In-Silico Approach. Ali A, Ali A, Warsi MH, Rahman MA, Ahsan MJ, Azam F. Curr Issues Mol Biol 44 1027-1045 (2022)
  45. Design of ligand binding to an engineered protein cavity using virtual screening and thermal up-shift evaluation. Machicado C, López-Llano J, Cuesta-López S, Bueno M, Sancho J. J Comput Aided Mol Des 19 421-443 (2005)
  46. High-throughput structural characterisation of therapeutic protein targets. Marsden BD, Sundstrom M, Knapp S. Expert Opin Drug Discov 1 123-136 (2006)
  47. MM/GBSA prediction of relative binding affinities of carbonic anhydrase inhibitors: effect of atomic charges and comparison with Autodock4Zn. Taylor M, Ho J. J Comput Aided Mol Des 37 167-182 (2023)
  48. Screening of rosmarinic acid from Salvia miltiorrhizae acting on the novel target TRPC1 based on the 'homology modelling-virtual screening-molecular docking-affinity assay-activity evaluation' method. Quan W, Wang Y, Chen YH, Shao Q, Gong YZ, Hu JW, Liu WH, Wu ZJ, Wang J, Ma SB, Li XQ. Pharm Biol 61 155-164 (2023)


Related citations provided by authors (1)

  1. Subnanomolar Inhibitors from Computer Screening: A Model Study Using Human Carbonic Anhydrase II. Grueneberg S, Wendt B, Klebe G Angew. Chem. Int. Ed. Engl. 40 389-393 (2001)

Quick links